Literature DB >> 19660550

Identification and functional dissection of localization signals within ataxin-3.

Paul Michel Aloyse Antony1, Simone Mäntele, Phillip Mollenkopf, Jana Boy, Ralph H Kehlenbach, Olaf Riess, Thorsten Schmidt.   

Abstract

Spinocerebellar ataxia type 3 (SCA3) or Machado-Joseph disease (MJD) belongs to a group of autosomal dominant neurodegenerative diseases, which are caused by the expansion of a polyglutamine repeat in the affected protein, in this case ataxin-3. Ataxin-3 is mainly localized in the cytoplasm; however, one hallmark of SCA3 is the formation of ataxin-3-containing protein aggregates in the nucleus of neurons. Currently, it is not known how mutant ataxin-3 translocates into the nucleus. We performed localization assays of recently proposed and novel potential signals, functionally confirmed the activity of a nuclear localization signal, identified two novel nuclear export signals (NES 77 and NES 141), and determined crucial amino acids. In addition, we demonstrate the relevance of the identified signals for the intracellular localization of the N- and C-terminus of ataxin-3. Our findings stress the importance of investigating the mechanisms, which influence the intracellular distribution of ataxin-3 during the pathogenesis of SCA3.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19660550     DOI: 10.1016/j.nbd.2009.07.020

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  14 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

2.  Divalproex sodium modulates nuclear localization of ataxin-3 and prevents cellular toxicity caused by expanded ataxin-3.

Authors:  Zi-Jian Wang; Aoife Hanet; Daniel Weishäupl; Inês M Martins; Anna S Sowa; Olaf Riess; Thorsten Schmidt
Journal:  CNS Neurosci Ther       Date:  2018-01-09       Impact factor: 5.243

3.  Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease.

Authors:  Vitor Carmona; Janete Cunha-Santos; Isabel Onofre; Ana Teresa Simões; Udaya Vijayakumar; Beverly L Davidson; Luís Pereira de Almeida
Journal:  Mol Ther       Date:  2017-02-22       Impact factor: 11.454

4.  Physiological and pathophysiological characteristics of ataxin-3 isoforms.

Authors:  Daniel Weishäupl; Juliane Schneider; Barbara Peixoto Pinheiro; Corinna Ruess; Sandra Maria Dold; Felix von Zweydorf; Christian Johannes Gloeckner; Jana Schmidt; Olaf Riess; Thorsten Schmidt
Journal:  J Biol Chem       Date:  2018-11-19       Impact factor: 5.157

5.  Proteotoxic stress increases nuclear localization of ataxin-3.

Authors:  Christopher P Reina; Xiaoyan Zhong; Randall N Pittman
Journal:  Hum Mol Genet       Date:  2009-10-19       Impact factor: 6.150

6.  Karyopherin α-3 is a key protein in the pathogenesis of spinocerebellar ataxia type 3 controlling the nuclear localization of ataxin-3.

Authors:  Anna Sergeevna Sowa; Elodie Martin; Inês Morgado Martins; Jana Schmidt; Reinhard Depping; Jonasz Jeremiasz Weber; Franziska Rother; Enno Hartmann; Michael Bader; Olaf Riess; Hervé Tricoire; Thorsten Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-23       Impact factor: 11.205

7.  Trinucleotide repeats: a structural perspective.

Authors:  Bruno Almeida; Sara Fernandes; Isabel A Abreu; Sandra Macedo-Ribeiro
Journal:  Front Neurol       Date:  2013-06-20       Impact factor: 4.003

8.  Valosin-containing protein (VCP/p97) is an activator of wild-type ataxin-3.

Authors:  Mário N Laço; Luisa Cortes; Sue M Travis; Henry L Paulson; A Cristina Rego
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

Review 9.  Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.

Authors:  Melvin M Evers; Lodewijk J A Toonen; Willeke M C van Roon-Mom
Journal:  Mol Neurobiol       Date:  2013-11-29       Impact factor: 5.590

Review 10.  From pathways to targets: understanding the mechanisms behind polyglutamine disease.

Authors:  Jonasz Jeremiasz Weber; Anna Sergeevna Sowa; Tina Binder; Jeannette Hübener
Journal:  Biomed Res Int       Date:  2014-09-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.